Antiplatelet De-Escalation Strategies in Patients Undergoing Percutaneous Coronary Intervention

Alessandro Spirito, Sriya L. Krishnan, Davide Capodanno, Dominick J. Angiolillo, Roxana Mehran

Research output: Contribution to journalReview articlepeer-review


Dual antiplatelet therapy - the combination of aspirin and a P2Y12 inhibitor - remains the standard antiplatelet regimen recommended to prevent ischemic complications immediately after percutaneous coronary intervention. Nonetheless, recent advances in stent technologies, percutaneous coronary intervention techniques, adjunctive pharmacotherapy for secondary prevention, and the rising awareness of the prognostic impact of bleeding, which are inevitably associated with dual antiplatelet therapy, led to the investigation of alternative antiplatelet regimens related to fewer bleeding and a preserved ischemic protection. Thrombotic complications occur mostly in the first months after percutaneous coronary intervention, while the risk of bleeding remains stable over time; this observation laid the foundation of the concept of antiplatelet de-escalation, consisting of a more intense antiplatelet regimen early after percutaneous coronary intervention, followed by a less potent antiplatelet therapy thereafter. According to new definitions proposed by the Academic Research Consortium, de-escalation can be achieved by discontinuation of 1 antiplatelet agent, switching from a potent P2Y12 inhibitor to clopidogrel, or by reducing the dose of antiplatelet agents. This review discusses the rationale and the evidence supporting antiplatelet de-escalation, provides practical guidance to use these new regimens, and gives insights into future developments in the field.

Original languageEnglish
Pages (from-to)E013263
JournalCirculation: Cardiovascular Interventions
Issue number4
StatePublished - 1 Apr 2024


  • coronary artery disease
  • percutaneous coronary intervention
  • platelet aggregation inhibitors
  • risk assessment


Dive into the research topics of 'Antiplatelet De-Escalation Strategies in Patients Undergoing Percutaneous Coronary Intervention'. Together they form a unique fingerprint.

Cite this